Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation

被引:128
作者
Kawazoe, Y
Naka, T
Fujimoto, M
Kohzaki, H
Morita, Y
Narazaki, M
Okumura, K
Saitoh, H
Nakagawa, R
Uchiyama, Y
Akira, S
Kishimoto, T
机构
[1] Osaka Univ, Sch Med, Dept Med 3, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Sch Med, Dept Cell Biol & Anat 1, Suita, Osaka 5650871, Japan
[3] Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan
[4] Biomol Engn Res Inst, Suita, Osaka 5650871, Japan
关键词
insulin; IRS-1; SSI-1/SOCS1; signaling; janus kinase; diabetes;
D O I
10.1084/jem.193.2.263
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1) is known to function as a negative feedback regulator of cytokine signaling, but it is unclear whether it is involved in other biological events. Here, we show that SSI-1 participates and plays an important role in the insulin signal transduction pathway. SSI-1-deficient mice showed a significantly low level of blood sugar. While the forced expression of SSI-1 reduced the phosphorylation level of insulin receptor substrate 1 (IRS-1), SSI-1 deficiency resulted in sustained phosphorylation of IRS-1 in response to insulin. Furthermore, SSI-1 achieves this inhibition both by binding directly to IRS-1 and by suppressing Janus kinases. These findings suggest that SSI-1 acts as a negative feedback factor also in the insulin signal transduction pathway through the suppression of IRS-1 phosphorylation.
引用
收藏
页码:263 / 269
页数:7
相关论文
共 24 条
[1]   ALTERNATIVE PATHWAY OF INSULIN SIGNALING IN MICE WITH TARGETED DISRUPTION OF THE IRS-1 GENE [J].
ARAKI, E ;
LIPES, MA ;
PATTI, ME ;
BRUNING, JC ;
HAAG, B ;
JOHNSON, RS ;
KAHN, CR .
NATURE, 1994, 372 (6502) :186-190
[2]   The role of SOCS-3 in leptin signaling and leptin resistance [J].
Bjorbæk, C ;
El-Haschimi, K ;
Frantz, JD ;
Flier, JS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (42) :30059-30065
[3]  
De Sepulveda P, 1999, EMBO J, V18, P904
[4]   SOCS-3 is an insulin-induced negative regulator of insulin signaling [J].
Emanuelli, B ;
Peraldi, P ;
Filloux, C ;
Sawka-Verhelle, D ;
Hilton, D ;
Van Obberghen, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (21) :15985-15991
[5]   A new protein containing an SH2 domain that inhibits JAK kinases [J].
Endo, TA ;
Masuhara, M ;
Yokouchi, M ;
Suzuki, R ;
Sakamoto, H ;
Mitsui, K ;
Matsumoto, A ;
Tanimura, S ;
Ohtsubo, M ;
Misawa, H ;
Miyazaki, T ;
Leonor, N ;
Taniguchi, T ;
Fujita, T ;
Kanakura, Y ;
Komiya, S ;
Yoshimura, A .
NATURE, 1997, 387 (6636) :921-924
[6]   INVOLVEMENT OF JANUS KINASES IN THE INSULIN SIGNALING PATHWAY [J].
GIORGETTI-PERALDI, S ;
PEYRADE, F ;
BARON, V ;
VAN OBBERGHEN, E .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 234 (02) :656-660
[7]   Interaction of Janus kinases JAK-1 and JAK-2 with the insulin receptor and the insulin-like growth factor-1 receptor [J].
Gual, P ;
Baron, V ;
Lequoy, V ;
Van Obberghen, E .
ENDOCRINOLOGY, 1998, 139 (03) :884-893
[8]   Negative regulators of cytokine signal transduction [J].
Hilton, DJ .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (12) :1568-1577
[9]  
HOTAMISLIGIL GS, 1999, EXP CLIN ENDOCRINOL, V2, P119
[10]   AN IL-4 RECEPTOR REGION CONTAINING AN INSULIN-RECEPTOR MOTIF IS IMPORTANT FOR IL4-MEDIATED IRS-1 PHOSPHORYLATION AND CELL-GROWTH [J].
KEEGAN, AD ;
NELMS, K ;
WHITE, M ;
WANG, LM ;
PIERCE, JH ;
PAUL, WE .
CELL, 1994, 76 (05) :811-820